Charles Faith L.
CIK 0001853985
Director
Filings
21
Latest May 20, 2026
Issuers covered
4
Showing
21 of 21
Page 1
Track record
3 of 4 open-market trades scored (75% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 67% | +8.2% | +6.3% | +25.8% | -7.4% |
| 90 days | 3 | 67% | +11.9% | +9.9% | +54.3% | -28.5% |
| 180 days | 3 | 67% | +5.1% | +10.5% | +91.7% | -86.9% |
| 365 days | 2 | 50% | +7.2% | +7.2% | +64.1% | -49.7% |
Issuers
Companies where Charles Faith L. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ABEO | Abeona Therapeutics Inc. | 8 | Jan 27, 2026 |
| CNSP | Cns Pharmaceuticals, Inc. | 6 | May 20, 2026 |
| CDT | Conduit Pharmaceuticals Inc. | 5 | Apr 17, 2025 |
| ATXI | Avenue Therapeutics, Inc. | 2 | Sep 25, 2024 |
All filings
21 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|